Fig. 3
From: Ablation of interleukin-19 improves motor function in a mouse model of amyotrophic lateral sclerosis
Ablation of IL-19 does not affect gliosis and neuronal loss in SOD1G93A Tg. a–c Images of lumbar spinal cord of SOD1G93A Tg and IL-19−/−/ SOD1G93A Tg mice at the late stage (20 weeks) and end stage (24 weeks), immunostained for (a) Iba1, (b) GFAP, and (c) NeuN. d Percentage of Iba1-positive areas in the lumbar spinal cord sections. e Percentage of GFAP-positive areas in the lumbar spinal cord sections. f Numbers of NeuN-positive cells in the ventral horn of lumbar spinal cord sections. Scale bar, 200 µm. Values are means ± SD